Skip to search.
 TSX Up 0.43% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Biogen Idec Inc. (BIIB)

-NasdaqGS
306.20 8.22(2.76%) Apr 22, 4:00PM EDT
Add to Portfolio
Prev Close:297.98
Open:300.50
Bid:310.00 x 100
Ask:315.00 x 100
1y Target Est:345.24
Beta:1.34
Next Earnings Date:23-Apr-14BIIB Earnings announcement
Day's Range:300.00 - 309.17
52wk Range:194.66 - 358.89
Volume:1,778,118
Avg Vol (3m):1,781,120
Market Cap:72.38B
P/E (ttm):39.21
EPS (ttm):7.81
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBUp 2.76%72.38B
PFE197.87B

Key Statistics

Forward P/E (1 yr):21.75
P/S (ttm):10.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :11.32
Quarterly EPS Est (Mar-14) :2.56
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.40

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback